lunes, 30 de julio de 2018

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations

Main|Search|PHGKB
a crowd vs a few people
From National Institutes of Health Web Sites

No hay comentarios:

Publicar un comentario